Skip to main content
Clinical Trials/CTRI/2024/07/071004
CTRI/2024/07/071004
Not yet recruiting
Phase 2

Single arm clinical study to assess the efficacy of shrungberadyaGhruta in amavata (rheumatoid arthritis) with special reference toC-reactive protein - NI

Dr Sanket Vaibhav Kamble0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: D839- Common variable immunodeficiency,unspecified
Sponsor
Dr Sanket Vaibhav Kamble
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Sanket Vaibhav Kamble

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient having the signs and symptoms of Amavata as per
  • Ayurveda view like sandhishool (pain at joints), sandhishotha
  • (swelling over joints), sandhi stabhdhata (stiffness over joints),
  • tivra sparshasahatva (tenderness over joints) upto 2 year.
  • 2\. The patients of Age group 20 to 60 years will be selected.
  • 3\. The patients will be selected irrespective of sex, religion.

Exclusion Criteria

  • 1\) The patients of age below 20 yrs and above 60 yrs.
  • 2\) Pregnancy, Lactating Mother.
  • 3\) Known case of Syphilitis Arthritis, Systemic Lupus Erythematosus,
  • Psoriatic Arthritis, Immune Compressed Diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials